Elite Pharmaceuticals Inc (ELTP)

[richme]

Unsubstantiated valuations couple with timely release of data did or certainly contributed to it. Investors were expecting 12 generics and at least one claim appeared that Elite already had 20-21 products in the market. Each little hypebit contributed to to the great nothing of a $.97 run and quick dive. Investors may have doubts that the valuations were true and certainly can see that NO NEW GENERICS have been launched under NasRAT. The PPS being at $.32 may in fact have nothing to do with NasRAT since JT achieved $.26 without any products albeit with help of hype. Tell me could be I am mistaken. How may products have been launched since NasRAT came onboard some 14 months ago? 1, 2, 3, or ZERO?